Keyword: Merck

News

Merck Serono Expands Biopharmaceuticals Lab

15.09.2015 - Merck Serono, the biopharmaceutical arm of Germany’s Merck KGaA, has laid the cornerstone for a new €65 million laboratory at its Darmstadt headquarters. When completed in 2017...

News

UK Health Agency Blesses Merck Cancer Drug

10.09.2015 - UK drug cost-effectiveness agency National Institute for Health and Care Excellence, NICE, has approved the use of US drugmaker Merck’s Keytruda for treatment of certain cases of...

Markets & Companies

Global Chemicals Markets Still Volatile and Challenging

04.09.2015 - Around the globe, market conditions for chemical industry players remained volatile and challenging, corporate chieftains said unanimously in reporting on the second quarter and...

Strategy & Management

Significant Value Creation

03.09.2015 - In September 2014, Merck announced the €13.1 billion acquisition of Sigma-Aldrich, which by mid-August has received antitrust clearance from all relevant jurisdictions including...

News

Germany’s Merck Wins Last Antitrust Nod for Sigma-Aldrich

12.08.2015 - With the unconditional approval of Brazil's Council for Economic Defense (CADE), German chemicals and pharmaceuticals producer Merck KGaA has taken the final antitrust hurdle for...

News

Codexis Licenses CodeEvolver Technology to US Merck

05.08.2015 - In its second licensing agreement with a major pharmaceutical company, Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries, has agreed to...

News

Germany’s Merck to Mentor Scheme Start-ups

05.08.2015 - German pharmaceuticals and chemicals group Merck KGaA has launched a program to encourage international start-ups in its business fields of healthcare, life sciences and...

News

Platform Offers $2.3 Billion for Alent

14.07.2015 - Private equity investor Platform Specialty Products has offered around $2.3 billion, including debt, for all shares of UK-based Alent, a manufacturer of electronic chemicals...